RBC Capital analyst Mark Dwelle lowered the firm’s price target on MetLife to $76 from $83 but keeps an Outperform rating on the shares. The analyst is updating the firm’s model to reflect the recently recast financial statements that incorporate new LDTI accounting standards. The firm remains positive on the stock however, noting that MetLife is trading at an attractive valuation and offers relatively lower sensitivity to interest rates and market volatility.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MET: